60 Degrees Pharmaceuticals, Inc. (SXTP) income statement
SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3064% below fair value
$0.47−0.03 (-6.36%)
Close on Nov 20, 2026Market cap $1.65MP/E –Yield –
60 Degrees Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?